The M&A between biotechnology companies and venture capitalists is a great opportunity for both sides. Venture capitalists have an array of interests and experience, and biotechnology is not far behind. Generally, these investors will consider any opportunity that involves a unique technology, and they will not be scared to take a risk. However, because biotechnology …
Continue reading “Biotechnology Companies and Venture Capitalists”
If you are thinking of doing a M-A between biotechnology companies, you may be wondering whether the two entities have the right kind of background. The good news is that both are highly motivated and experienced individuals who are likely to benefit from the alignment of interests between both parties. Venture capitalists are typically men …
It will be possible to fight bacteria resistant to antibiotics with the help of a polymer molecule. If the researchers succeed in proving the safety of such treatment, then doctors may have a new effective method of dealing with dangerous deadly infections. A group of scientists from the IBM Almaden Research Center (USA) and the …
Continue reading “Synthetic molecule can replace antibiotic”
